Diana Jaber1, Fabian Vargas2, Linh Nguyen3, Joanna Ringel2, Kate Zarzuela2, Mahad Musse2, Min Ji Kwak4, Emily B Levitan5, Mathew S Maurer6, Mark S Lachs2, Monika M Safford2, Parag Goyal7. 1. School of Medicine & Health Sciences, George Washington University, Washington, DC. 2. Department of Medicine, Weill Cornell Medicine, New York, New York. 3. School of Medicine, University of Colorado, Aurora, Colorado. 4. Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center, Houston, Texas. 5. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama. 6. Department of Medicine, Columbia University Irving Medical Center, New York, New York. 7. Department of Medicine, Weill Cornell Medicine, New York, New York. Electronic address: pag9051@med.cornell.edu.
Abstract
BACKGROUND: We sought to better understand patterns of potentially inappropriate medications (PIMs) from the Beers criteria among older adults hospitalized with heart failure (HF). This observational study of hospitalizations was derived from the geographically diverse REasons for Geographic and Racial Differences in Stroke cohort. METHODS AND RESULTS: We examined participants aged 65 years and older with an expert-adjudicated hospitalization for HF. The Beers criteria medications were abstracted from medical records. The prevalence of PIMs was 61.1% at admission and 64.0% at discharge. Participants were taking a median of 1 PIM (interquartile range [IQR] 0-1 PIM) at hospital admission and a median of 1 PIM (IQR 0-2 PIM) at hospital discharge. Between admission and discharge, 19.1% of patients experienced an increase in the number of PIMs, 15.1% experienced a decrease, and 37% remained on the same number between hospital admission and discharge. The medications with the greatest increase from admission to discharge were proton pump inhibitors (32.6% to 38.6%) and amiodarone (6.2% to 12.2%). The strongest determinant of potentially harmful prescribing patterns was polypharmacy (relative risk 1.34, 95% confidence interval 1.16-1.55, P < .001). CONCLUSIONS: PIMs are common among older adults hospitalized for HF and may be an important target to improve outcomes in this vulnerable population.
BACKGROUND: We sought to better understand patterns of potentially inappropriate medications (PIMs) from the Beers criteria among older adults hospitalized with heart failure (HF). This observational study of hospitalizations was derived from the geographically diverse REasons for Geographic and Racial Differences in Stroke cohort. METHODS AND RESULTS: We examined participants aged 65 years and older with an expert-adjudicated hospitalization for HF. The Beers criteria medications were abstracted from medical records. The prevalence of PIMs was 61.1% at admission and 64.0% at discharge. Participants were taking a median of 1 PIM (interquartile range [IQR] 0-1 PIM) at hospital admission and a median of 1 PIM (IQR 0-2 PIM) at hospital discharge. Between admission and discharge, 19.1% of patients experienced an increase in the number of PIMs, 15.1% experienced a decrease, and 37% remained on the same number between hospital admission and discharge. The medications with the greatest increase from admission to discharge were proton pump inhibitors (32.6% to 38.6%) and amiodarone (6.2% to 12.2%). The strongest determinant of potentially harmful prescribing patterns was polypharmacy (relative risk 1.34, 95% confidence interval 1.16-1.55, P < .001). CONCLUSIONS: PIMs are common among older adults hospitalized for HF and may be an important target to improve outcomes in this vulnerable population.
Authors: Ashok Krishnaswami; Michael A Steinman; Parag Goyal; Andrew R Zullo; Timothy S Anderson; Kim K Birtcher; Sarah J Goodlin; Mathew S Maurer; Karen P Alexander; Michael W Rich; Jennifer Tjia Journal: J Am Coll Cardiol Date: 2019-05-28 Impact factor: 24.094
Authors: Kevin S Shah; Haolin Xu; Roland A Matsouaka; Deepak L Bhatt; Paul A Heidenreich; Adrian F Hernandez; Adam D Devore; Clyde W Yancy; Gregg C Fonarow Journal: J Am Coll Cardiol Date: 2017-11-12 Impact factor: 24.094
Authors: Jesse Jansen; Vasi Naganathan; Stacy M Carter; Andrew J McLachlan; Brooke Nickel; Les Irwig; Carissa Bonner; Jenny Doust; Jim Colvin; Aine Heaney; Robin Turner; Kirsten McCaffery Journal: BMJ Date: 2016-06-03
Authors: Michael A Steinman; Yinghui Miao; W John Boscardin; Kiya D R Komaiko; Janice B Schwartz Journal: J Gen Intern Med Date: 2014-07-08 Impact factor: 5.128
Authors: Parag Goyal; Jerard Kneifati-Hayek; Alexi Archambault; Krisha Mehta; Emily B Levitan; Ligong Chen; Ivan Diaz; James Hollenberg; Joseph T Hanlon; Mark S Lachs; Mathew S Maurer; Monika M Safford Journal: JACC Heart Fail Date: 2019-11-06 Impact factor: 12.035